1. Home
  2. IMNM vs BH Comparison

IMNM vs BH Comparison

Compare IMNM & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • BH
  • Stock Information
  • Founded
  • IMNM 2006
  • BH 1934
  • Country
  • IMNM United States
  • BH United States
  • Employees
  • IMNM N/A
  • BH N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • BH Restaurants
  • Sector
  • IMNM Health Care
  • BH Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • BH Nasdaq
  • Market Cap
  • IMNM 748.3M
  • BH 681.4M
  • IPO Year
  • IMNM 2020
  • BH N/A
  • Fundamental
  • Price
  • IMNM $9.06
  • BH $253.03
  • Analyst Decision
  • IMNM Strong Buy
  • BH
  • Analyst Count
  • IMNM 5
  • BH 0
  • Target Price
  • IMNM $26.40
  • BH N/A
  • AVG Volume (30 Days)
  • IMNM 973.9K
  • BH 32.4K
  • Earning Date
  • IMNM 05-12-2025
  • BH 05-09-2025
  • Dividend Yield
  • IMNM N/A
  • BH N/A
  • EPS Growth
  • IMNM N/A
  • BH N/A
  • EPS
  • IMNM N/A
  • BH N/A
  • Revenue
  • IMNM $10,938,000.00
  • BH $367,698,000.00
  • Revenue This Year
  • IMNM N/A
  • BH N/A
  • Revenue Next Year
  • IMNM $542.22
  • BH N/A
  • P/E Ratio
  • IMNM N/A
  • BH N/A
  • Revenue Growth
  • IMNM N/A
  • BH 0.85
  • 52 Week Low
  • IMNM $5.15
  • BH $159.69
  • 52 Week High
  • IMNM $16.81
  • BH $271.35
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 61.94
  • BH 60.81
  • Support Level
  • IMNM $8.50
  • BH $244.01
  • Resistance Level
  • IMNM $9.04
  • BH $267.00
  • Average True Range (ATR)
  • IMNM 0.54
  • BH 9.71
  • MACD
  • IMNM 0.09
  • BH 0.58
  • Stochastic Oscillator
  • IMNM 90.18
  • BH 62.12

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.

Share on Social Networks: